Clinical Trial Update: Safety Study of an Adeno-associated Virus Vector for Gene Therapy of Leber's Hereditary Optic Neuropathy [Phase 1]

View source ↗

Summary

Phase 1 safety study of an adeno-associated virus vector gene therapy for Leber hereditary optic neuropathy has completed enrollment. Results were posted on 202…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leber Hereditary Optic Neuropathy

Snippet

Sponsor: Byron Lam | Conditions: Leber's Hereditary Optic Neuropathy | Phase 1 | Status: COMPLETED | Results posted: 2024-08-07